Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma
  1. Home
  2. Publications
  3. Supplementary Table S1 from Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma

Supplementary Table S1 from Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma

Authors:
  • LHLorena Heinst
    Lorena Heinst
  • KLKwang Seok Lee
    Kwang Seok Lee
  • RBRuth Berthold
    Ruth Berthold
  • IIIlka Isfort
    Ilka Isfort
  • SWSvenja Wosnig
    Svenja Wosnig
  • AKAnna Kuntze
    Anna Kuntze
  • SHSusanne Hafner
    Susanne Hafner
  • BABianca Altvater
    Bianca Altvater
  • CRClaudia Rossig
    Claudia Rossig
  • PÅPierre Åman
    Pierre Åman
  • EWEva Wardelmann
    Eva Wardelmann
  • CSClaudia Scholl
    Claudia Scholl

Open Access
Publisher website
Google Scholar
  • 1 November 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.27434018
Abstract
Supplementary Table S1. Primary antibodies.
Keywords
  • CELL CYCLE
  • CELL CYCLE CHECKPOINTS
  • SARCOMAS
  • SOFT-TISSUE SARCOMA
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.